Why do fnac test

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Fine Needle Aspiration Cytology (FNAC) tests are performed to diagnose suspicious lumps or masses, particularly in organs like the thyroid, breast, or lymph nodes. It involves using a thin needle to extract cells for microscopic examination, helping distinguish between benign and malignant conditions with high accuracy—studies show sensitivity rates of 80-95% for thyroid nodules. FNAC is preferred for its minimal invasiveness, quick results (often within 24-48 hours), and low complication rates compared to surgical biopsies.

Key Facts

FNAC was first described in the 1930s by Martin and Ellis at Memorial Hospital in New York
The procedure typically uses a 22-27 gauge needle, thinner than standard injection needles
Accuracy rates for thyroid FNAC reach 95% when combined with ultrasound guidance
Complication rates are less than 1%, mainly minor bleeding or infection
Results are categorized using the Bethesda System for thyroid cytology (6 categories)

Overview

Fine Needle Aspiration Cytology (FNAC) is a diagnostic procedure used to investigate palpable masses or lesions detected through imaging. Developed in the 1930s by Drs. Hayes Martin and Edward Ellis at Memorial Hospital in New York, it gained widespread adoption in the 1970s with improved cytological techniques. FNAC serves as a first-line diagnostic tool for evaluating suspicious lumps in various body sites, most commonly the thyroid (accounting for approximately 50% of FNAC procedures), breast, lymph nodes, salivary glands, and soft tissues. The procedure is particularly valuable in cancer diagnosis, helping determine whether a mass is benign or malignant before deciding on surgical intervention. Its minimally invasive nature makes it suitable for outpatient settings, reducing healthcare costs and patient discomfort compared to open biopsies.

How It Works

FNAC involves inserting a thin needle (typically 22-27 gauge) into a suspicious mass under local anesthesia or imaging guidance. The practitioner applies suction with a syringe to aspirate cellular material, which is then smeared onto glass slides for staining and microscopic examination by a cytopathologist. For non-palpable lesions, ultrasound guidance improves accuracy—studies show ultrasound-guided FNAC has 90-95% sensitivity for thyroid nodules. The aspirated cells are analyzed for architectural patterns, nuclear features, and cytoplasmic characteristics to classify lesions as benign, atypical, suspicious, or malignant. The Bethesda System for Reporting Thyroid Cytopathology (established in 2007) standardizes thyroid FNAC interpretations into six categories with corresponding cancer risks ranging from 0-3% to 97-99%. Results are typically available within 24-48 hours, allowing rapid clinical decision-making.

Why It Matters

FNAC significantly impacts patient care by enabling early, accurate diagnosis while avoiding unnecessary surgeries. For thyroid nodules, FNAC helps identify the 5-15% that are malignant, preventing overtreatment of benign conditions. In breast cancer diagnosis, FNAC combined with imaging has reduced open biopsy rates by 30-50% in some settings. The procedure's low cost (approximately $200-500 versus $2000+ for surgical biopsy) and minimal recovery time make it accessible in resource-limited environments. FNAC also guides treatment planning—for example, identifying lymphoma subtypes or metastatic cancers. Despite limitations like sampling errors (5-10% of cases) and indeterminate results requiring repeat testing, FNAC remains essential in modern diagnostic algorithms, particularly in cancer screening programs worldwide.